Neoplasm, Nerve Tissue
1 clinical trials · Condition
◉ Watch Neoplasm, Nerve Tissue
| Record | Firm | Date |
|---|---|---|
| Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (NCT02798406) | DNAtrix, Inc. | 2016-10-06 |
Track Neoplasm, Nerve Tissue automatically
Every clearance here is in the API, with alerts when new ones post.